{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:12:41Z","timestamp":1790957561045,"version":"4.1.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Clinics of North America"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.mcna.2016.08.009","type":"journal-article","created":{"date-parts":[[2016,11,22]],"date-time":"2016-11-22T04:33:04Z","timestamp":1479789184000},"page":"129-137","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":149,"title":["The Renin Angiotensin Aldosterone System in Obesity and Hypertension"],"prefix":"10.1016","volume":"101","author":[{"given":"Peminda K.","family":"Cabandugama","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Gardner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R.","family":"Sowers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mcna.2016.08.009_bib1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000323352","article-title":"The cardiorenal syndrome: basis and common ground for a multidisciplinary patient-oriented therapy","volume":"1","author":"Ronco","year":"2011","journal-title":"Cardiorenal Med"},{"key":"10.1016\/j.mcna.2016.08.009_bib2","unstructured":"Available at: http:\/\/www.cdc.gov\/nchs\/data\/nhis\/earlyrelease\/earlyrelease201602_06.pdf. Accessed June 20, 2016."},{"issue":"3","key":"10.1016\/j.mcna.2016.08.009_bib3","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1053\/j.ajkd.2014.09.023","article-title":"The future burden of CKD in the United States: a simulation model for the CDC CKD Initiative","volume":"65","author":"Hoerger","year":"2015","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"10.1016\/j.mcna.2016.08.009_bib4","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/oby.20181","article-title":"Obesity related hypertension: pathogenesis, cardiovascular risk, and treatment-a position paper of the obesity society and the American society of hypertension","volume":"21","author":"Landsberg","year":"2013","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.mcna.2016.08.009_bib5","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3389\/fendo.2013.00161","article-title":"The role of tissue renin-angiotensin-aldosterone system in the development of endothelial dysfunction and arterial stiffness","volume":"4","author":"Aroor","year":"2013","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.mcna.2016.08.009_bib6","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/nrendo.2014.44","article-title":"The pathophysiology of hypertension in patients with obesity","volume":"10","author":"Demarco","year":"2014","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.mcna.2016.08.009_bib7","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1159\/000368423","article-title":"Insulin resistance and skeletal muscle vasculature: Significance, assessment and therapeutic modulators","volume":"4","author":"Manrique","year":"2014","journal-title":"Cardiorenal Med"},{"issue":"1","key":"10.1016\/j.mcna.2016.08.009_bib8","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1001\/archinte.1981.00340010073016","article-title":"Obesity and essential hypertension. hemodynamics, intravascular volume, sodium excretion, and plasma renin activity","volume":"141","author":"Messerli","year":"1981","journal-title":"Arch Intern Med"},{"issue":"5 Pt 2","key":"10.1016\/j.mcna.2016.08.009_bib9","first-page":"III71","article-title":"The problem of obesity and hypertension","volume":"5","author":"Frohlich","year":"1983","journal-title":"Hypertension"},{"issue":"10","key":"10.1016\/j.mcna.2016.08.009_bib10","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/jch.12399","article-title":"Adipokines: novel players in resistant hypertension","volume":"16","author":"De Faria","year":"2014","journal-title":"J\u00a0Clin Hypertens"},{"key":"10.1016\/j.mcna.2016.08.009_bib11","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1161\/HYPERTENSIONAHA.114.00920","article-title":"Obesity associated hypertension: recent progress in deciphering the pathogenesis","volume":"64","author":"Rahmouni","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/j.mcna.2016.08.009_bib12","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.2337\/db15-0096","article-title":"Role of perivascular adipose tissue on vascular reactive oxygen species in type 2 diabetes: a give and take relationship","volume":"64","author":"Padilla","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/j.mcna.2016.08.009_bib13","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S1357-2725(02)00311-4","article-title":"The adipose tissue renin-angiotensin-aldosterone system: role in the metabolic syndrome?","volume":"35","author":"Engeli","year":"2003","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/j.mcna.2016.08.009_bib14","doi-asserted-by":"crossref","first-page":"5220","DOI":"10.1210\/endo.142.12.8556","article-title":"Angiotensinogen-deficient mice exhibit impairment of diet-induced weight gain with alteration in adipose tissue development and increased locomotor activity","volume":"142","author":"Massiera","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.mcna.2016.08.009_bib15","doi-asserted-by":"crossref","first-page":"991","DOI":"10.2337\/diabetes.54.4.991","article-title":"Deletion of the angiotensin type 2 receptor reduces adipose cell size and protects from diet-induced obesity and insulin resistance","volume":"54","author":"Yvan-Charvet","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.mcna.2016.08.009_bib16","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1161\/HYPERTENSIONAHA.112.192690","article-title":"Adipocyte deficiency of angiotensinogen prevents obesity-induced hypertension in male mice","volume":"60","author":"Yiannikouris","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.mcna.2016.08.009_bib17","doi-asserted-by":"crossref","first-page":"C82","DOI":"10.1152\/ajpcell.00287.2006","article-title":"Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system","volume":"292","author":"Mehta","year":"2007","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.mcna.2016.08.009_bib18","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1161\/HYPERTENSIONAHA.111.190223","article-title":"Adipocytes produce aldosterone through calcineurin-dependent signaling pathways: implications in diabetes mellitus-associated obesity and vascular dysfunction","volume":"59","author":"Briones","year":"2012","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.mcna.2016.08.009_bib19","doi-asserted-by":"crossref","first-page":"313","DOI":"10.2337\/db12-0905","article-title":"Mineralocorticoid receptor-mediated vascular insulin resistance: an early contributor to diabetes-related vascular disease?","volume":"62","author":"Bender","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.mcna.2016.08.009_bib20","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1161\/CIRCRESAHA.115.308269","article-title":"Endothelial mineralocorticoid receptor mediates diet-induced aortic stiffness in females","volume":"118","author":"Jia","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.mcna.2016.08.009_bib21","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1161\/01.HYP.17.5.669","article-title":"Relation of obesity and diet to sympathetic nervous system activity","volume":"17","author":"Troisi","year":"1991","journal-title":"Hypertension"},{"key":"10.1016\/j.mcna.2016.08.009_bib22","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1161\/01.HYP.0000147893.08533.d8","article-title":"Sympathetic neural activation in nondiabetic metabolic syndrome and its further augmentation by hypertension","volume":"44","author":"Huggett","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.mcna.2016.08.009_bib23","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1161\/01.HYP.0000151325.83008.b4","article-title":"Obesity associated hypertension: new insights into mechanisms","volume":"25","author":"Raumouni","year":"2005","journal-title":"Hypertension"},{"key":"10.1016\/j.mcna.2016.08.009_bib24","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1172\/JCI119532","article-title":"Receptor-mediated regional sympathetic nerve activation by leptin","volume":"100","author":"Haynes","year":"1997","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.mcna.2016.08.009_bib25","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.1210\/jcem.84.10.5999","volume":"84","author":"Ozata","year":"1999","journal-title":"J\u00a0Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.mcna.2016.08.009_bib26","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2147\/vhrm.2006.2.2.163","article-title":"Leptin and hypertension in obesity","volume":"2","author":"Bravo","year":"2006","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/j.mcna.2016.08.009_bib27","doi-asserted-by":"crossref","first-page":"R1730","DOI":"10.1152\/ajpregu.90324.2008","article-title":"Mechanisms mediating renal sympathetic activation to leptin in obesity","volume":"295","author":"Morgan","year":"2008","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/j.mcna.2016.08.009_bib28","doi-asserted-by":"crossref","first-page":"H2009","DOI":"10.1152\/ajpheart.00522.2007","article-title":"Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance","volume":"293","author":"Cooper","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.mcna.2016.08.009_bib29","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1097\/00004872-199917100-00013","article-title":"Fasting insulin and leptin levels are associated with systolic blood pressure independent of percentage body fat and body fat mass index","volume":"17","author":"Kazumi","year":"1999","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.mcna.2016.08.009_bib30","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1097\/00004872-200110000-00003","article-title":"Renin-angiotensin-sympathetic crosstalks in hypertension: reappraising the relevance of peripheral interactions","volume":"19","author":"Grassi","year":"2001","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.mcna.2016.08.009_bib31","doi-asserted-by":"crossref","first-page":"1827","DOI":"10.1097\/00004872-200110000-00017","article-title":"Angiotensin converting enzyme inhibition improves cardiac neuronal uptake of noradrenaline in spontaneously hypertensive rats","volume":"19","author":"Raasch","year":"2001","journal-title":"J\u00a0Hypertens"},{"key":"10.1016\/j.mcna.2016.08.009_bib32","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1161\/01.HYP.25.4.560","article-title":"Sympathetic activation in obese normotensive subjects","volume":"25","author":"Grassi","year":"1995","journal-title":"Hypertension"},{"key":"10.1016\/j.mcna.2016.08.009_bib33","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.2337\/diacare.28.9.2261","article-title":"The impact of ACE inhibitors or angiotensin II type 1 receptor blockers on the development of new-onset type 2 diabetes","volume":"28","author":"Gillespie","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.mcna.2016.08.009_bib34","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S1262-3636(07)70146-5","article-title":"Renin-angiotensin system inhibition prevents type 2 diabetes mellitus. Part 1. A meta-analysis of randomized clinical trials","volume":"30","author":"Scheen","year":"2004","journal-title":"Diabetes Metab"},{"issue":"1","key":"10.1016\/j.mcna.2016.08.009_bib35","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1161\/01.HYP.30.1.140","article-title":"For the Treatment in Obese Patients with Hypertension (TROPHY) study group","volume":"30","author":"Reisin","year":"1997","journal-title":"Hypertension"},{"key":"10.1016\/j.mcna.2016.08.009_bib36","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1475-2840-6-12","article-title":"Irbesartan for the treatment of hypertension in patients with the metabolic syndrome: a sub analysis of the treat to target post authorization survey. Prospective, observational two armed study in 14, 200 patients","volume":"6","author":"Kintscher","year":"2007","journal-title":"Cardiovasc Diabetol"},{"issue":"12","key":"10.1016\/j.mcna.2016.08.009_bib37","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1111\/j.1751-7176.2008.00054.x","article-title":"Metabolic and antihypertensive effects of combined angiotensin receptor blocker and diuretic therapy in prediabetic hypertensive patients with the cardiometabolic syndrome","volume":"10","author":"Zappe","year":"2008","journal-title":"J\u00a0Clin Hypertens"},{"issue":"23","key":"10.1016\/j.mcna.2016.08.009_bib38","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1056\/NEJMoa1208799","article-title":"Cardiorenal end points in a trial of Aliskiren for type 2 diabetes","volume":"367","author":"Parving","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"3","key":"10.1016\/j.mcna.2016.08.009_bib39","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1177\/1470320313497328","article-title":"Review of direct renin inhibition by Aliskiren","volume":"14","author":"Friedrich","year":"2013","journal-title":"J\u00a0Renin Angiotensin Aldosterone Syst"},{"key":"10.1016\/j.mcna.2016.08.009_bib40","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1097\/01.hjh.0000431740.32696.cc","article-title":"2013 ESH\/ESC guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and the European Society of Cardiology (ESC)","volume":"31","author":"Mancia","year":"2013","journal-title":"J\u00a0Hypertens"},{"issue":"5","key":"10.1016\/j.mcna.2016.08.009_bib41","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"2014 Evidence based guideline for the management of high blood pressure in adults: report from the panel members appointment to the eighth Joint National Committee (JNC 8)","volume":"311","author":"James","year":"2014","journal-title":"JAMA"},{"issue":"19","key":"10.1016\/j.mcna.2016.08.009_bib42","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.mcna.2016.08.009_bib43","series-title":"Hypertension: the clinical management of primary hypertension in adults: update of clinical guidelines 18 to 34","author":"National Clinical Guideline Centre","year":"2011"},{"issue":"5","key":"10.1016\/j.mcna.2016.08.009_bib44","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.cjca.2014.02.002","article-title":"The 2014 Canadian hypertension education program recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention and treatment of hypertension","volume":"30","author":"Dasqupta","year":"2014","journal-title":"Can J Cardiol"}],"container-title":["Medical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002571251637328X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002571251637328X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,4,5]],"date-time":"2021-04-05T05:55:51Z","timestamp":1617602151000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002571251637328X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S002571251637328X"],"URL":"https:\/\/doi.org\/10.1016\/j.mcna.2016.08.009","relation":{},"ISSN":["0025-7125"],"issn-type":[{"value":"0025-7125","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Renin Angiotensin Aldosterone System in Obesity and Hypertension","name":"articletitle","label":"Article Title"},{"value":"Medical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcna.2016.08.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}